News from orexo A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Apr 28, 2022, 02:48 ET Orexo Interim Report Q1 2022

Promising start to 2022 Q1 2022 highlights Total net revenues of SEK 159.4 m (132.3) EBITDA of SEK 2.8 m (-23.9) Net earnings of SEK -23.6 m (-31.5)...

Apr 27, 2022, 02:22 ET Orexo´s partner Gesynta Pharma granted Orphan Drug Designation by the FDA for OX-MPI (GS-248) for the treatment of systemic sclerosis

Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), announces today that the company´s partner Gesynta Pharma AB which owns all the rights to OX-MPI (GS248),...

Apr 21, 2022, 12:13 ET Report from Orexo AB's annual general meeting

Election of the board of directors and auditor The annual general meeting in Orexo AB (publ) on 21 April 2022 resolved, in accordance with the...

Mar 31, 2022, 02:28 ET Orexo publishes 2021 Annual Report

Orexo's Annual Report for the 2021 has been published. The Annual Report can be downloaded on the company's website, www.orexo.com, and a PDF is...

Mar 21, 2022, 11:59 ET Notice of Annual General Meeting of Orexo

The shareholders in Orexo AB (publ), reg. no. 556500-0600, registered office Uppsala, are summoned to the annual general meeting, to be held on...

Mar 11, 2022, 02:17 ET Orexo appoints Fredrik Järrsten as new CFO

Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), announces today that the company has appointed Fredrik Järrsten as new Chief Financial Officer (CFO) and a ...

Feb 24, 2022, 02:27 ET Orexo's lead product ZUBSOLV® added to NY State Medicaid MAT Preferred Drug List

Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), announced today information about improved market access position for ZUBSOLV® (buprenorphine and...

Jan 27, 2022, 02:23 ET Orexo Q4 2021, incl. Full Year Report

Ready to capitalize on a strong foundation Q4 2021 highlights Total net revenues of SEK 144.0 m (159.2) Net earnings of SEK -66.0 m (-49.6) EBITDA of ...

Dec 02, 2021, 02:21 ET Orexo develops a nasal adrenaline medication based on the novel amorphOXTM platform

Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY) today announces it has initiated a new pharmaceutical development project, OX640, a nasal adrenaline...

Nov 26, 2021, 02:27 ET Orexo provides information about its new proprietary drug delivery platform - amorphOXTM

Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) today provides information about its new proprietary drug delivery platform, amorphOXTM, a novel and...

Nov 16, 2021, 02:21 ET Orexo announces positive results from pivotal trial for its leading pharmaceutical pipeline asset OX124

Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) today announces that the company has successfully completed the pivotal trial (OX124-002) for its lead...

Nov 03, 2021, 03:37 ET Orexo Q3 2021 Interim Report

Q3 2021 highlights Total net revenues of SEK 145.9 m (150.3) Net earnings of -52.0 SEK m (-84.9) EBITDA of SEK -47.4 m (-20.9) US Pharma segment...

Nov 01, 2021, 03:33 ET Orexo´s Nomination Committee for the Annual General Meeting 2022

Prior to the Annual General Meeting (AGM) in 2022, Orexo has appointed a Nomination Committee which represents approximately 38 percent of the number ...

Oct 18, 2021, 02:12 ET MODIA™ paper published in the Journal of Medical Internet Research Mental Health

Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY) today announced the publication of a manuscript, "A Personalized, Interactive, Cognitive-Behavioral...

Jul 16, 2021, 02:49 ET Orexo's flagship pharmaceutical pipeline asset OX124 enters pivotal trial

Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) today announces that the company has successfully initiated the pivotal trial (OX124-002) for its lead...

Jul 16, 2021, 02:47 ET Orexo's flagship pharmaceutical pipeline asset OX124 enters pivotal trial

Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) today announces that the company has successfully initiated the pivotal trial (OX124-002) for its lead...

Jul 15, 2021, 02:56 ET Orexo Q2 2021 Interim Report

"First commercial DTx contract signed with a large healthcare provider" Summary Total net revenues of SEK 142.8 m (179.1) Net earnings of SEK -73.7 m ...

Jul 15, 2021, 02:55 ET Orexo Q2 2021 Interim Report

"First commercial DTx contract signed with a large healthcare provider" Summary Total net revenues of SEK 142.8 m (179.1) Net earnings of SEK -73.7 m ...

Jul 12, 2021, 08:15 ET Sober Grid Users to Gain Access to Clinically Proven Digital Therapeutics Through New Commercial Partnership with Orexo

Sober Grid, the largest social media network for those in addiction recovery, and Orexo, a Swedish pharmaceutical company, today announced that Sober ...

Jul 12, 2021, 02:33 ET Orexo signs commercial partnership agreement with Sober Grid allowing community users access to clinically proven digital therapies vorvida® and deprexis®

Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) and Sober Grid, the largest social media network for those in addiction recovery, today announced that...

Jul 01, 2021, 02:21 ET Orexo announces first patient enrolled in pivotal study evaluating the efficacy of modia™ in combination with sublingual buprenorphine/ naloxone for the treatment of OUD

Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), today announces the enrollment of the first participant in the pivotal study of digital therapeutic...

Jun 02, 2021, 02:28 ET Orexo continues to strengthen ZUBSOLV´s patent portfolio with two new patents

Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) today announces that the US Patent and Trademark Office (USPTO) has issued another two patents relating to...

Apr 29, 2021, 02:28 ET Orexo Q1 2021 Interim Report

Q1 2021 summary Total net revenues of SEK 132.3 m (175.0) Net earnings of SEK -31.5 m (82.6) EBITDA of SEK -23.9 m (39.1) US Pharma segment (ZUBSOLV® ...

Feb 10, 2021, 02:50 ET Orexo starts to test modia™ on patients in collaboration with ApexB.io and Magellan Rx Management

Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY) today announces the company will collaborate with ApexB.io and Magellan Rx Management to further research ...

Feb 05, 2021, 10:45 ET Orexo calls for redemption of its outstanding bonds and obtains temporary waiver

Orexo AB (publ.), ("Orexo" or the "Company") (STO:ORX) (OTCQX:ORXOY) ") has today given notice to all holders of the Company's maximum SEK...